These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9352177)

  • 1. The impact of lipid lowering in coronary artery disease.
    Goldberg AC
    Curr Opin Cardiol; 1997 Sep; 12(5):488-93. PubMed ID: 9352177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
    Stewart BF; Brown BG; Zhao XQ; Hillger LA; Sniderman AD; Dowdy A; Fisher LD; Albers JJ
    J Am Coll Cardiol; 1994 Mar; 23(4):899-906. PubMed ID: 8106695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials.
    White CW
    Am J Med; 1998 Jul; 105(1A):63S-68S. PubMed ID: 9707270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    Post Coronary Artery Bypass Graft Trial Investigators
    N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein cholesterol: is lower better?
    Leiter LA
    Can J Cardiol; 2000 Jan; 16 Suppl A():20A-2A. PubMed ID: 10653927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?
    Deslypere JP
    Int J Clin Pract; 2000 Jun; 54(5):307-13. PubMed ID: 10954957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies.
    Archbold RA; Timmis AD
    Curr Opin Lipidol; 1999 Dec; 10(6):527-34. PubMed ID: 10680047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia in older adults.
    Aslam F; Haque A; Lee LV; Foody J
    Clin Geriatr Med; 2009 Nov; 25(4):591-606, vii. PubMed ID: 19944263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL cholesterol: should guidelines include targets?
    Banerjee S; Kahali D; Banerjee A; Brilakis ES
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):285-90. PubMed ID: 24502625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid lowering after percutaneous coronary intervention. Intended and achieved treatment goals in real life].
    Germing A; Lindstaedt M; Mügge A
    Med Klin (Munich); 2005 Dec; 100(12):781-4. PubMed ID: 16453092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we aggressive enough in lowering cholesterol?
    Waters DD
    Am J Cardiol; 2001 Aug; 88(4A):10F-5F. PubMed ID: 11520481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
    MMW Fortschr Med; 2006 Nov; 148(48):54-5. PubMed ID: 17615773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.